Abstract:Lupus, Ahead of Print. ObjectiveSubstantial morbidity and mortality affect those with antiphospholipid antibodies (aPLs) and antiphospholipid syndrome (APS), yet patient experiences remain poorly understood. This research investigated patient experiences of aPL/APS diagnosis; effects on daily life; and healthcare and treatment.MethodsPatients aged ≥18 years with APS per the Revised Sapporo criteria or with ≥1 positive aPL on ≥2 occasions were recruited from a Canadian multidisciplinary APS clinic to participate in semi-structured in-depth interviews. Interviews were conducted virtually and transcribed verbatim for subsequent thematic analysis.ResultsTwenty-one patients with aPLs/APS participated; 95.2% were female, mean (SD) age was 45.6 (15.0) years. Most (71.4%) had APS, and 71.4% had aPLs/APS with SLE. Results are presented around patient experiences of aPL/APS diagnosis, effects on daily life, and healthcare and treatment. Participants described medical complications/physical symptoms and the healthcare, lifestyle, and emotional impacts experienced around the time of aPLs/APS diagnosis. In addition to the physical and psychosocial impacts of living with aPLs/APS, patients reported modified leisure activities, altered employment trajectories, and positive and negative impacts on relationships. Impacts on family planning were also a critical component of the aPL/APS lived experience; participants shared experiences of miscarriage, other pregnancy complications, and medication-related challenges (e.g., with low-molecular-weight heparin injections). Challenging aspects of aPL/APS healthcare and treatment were also discussed, particularly related to the lifestyle, physical, and emotional burden of medication use. Although a lack of resources was described, participants expressed trust in healthcare providers when making management decisions or when seeking information. Suggestions for resources included the need for additional medication-related information, examples to help contextualize management behaviours, and additional information for those with aPLs/APS without SLE.ConclusionPatients highlighted how the diverse manifestations of aPLs/APS, accentuated by management-related challenges, impose considerable physical and psychosocial burdens. Results will inform the development of patient resources aligned with patient priorities.

New advances in genomics and epigenetics in antiphospholipid syndrome

Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy.

Insights into Molecular Mechanisms and Clinical Manifestations

An update on inflammation in antiphospholipid syndrome

An Update on Antiphospholipid Syndrome

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

Obstetric Anti-phospholipid Syndrome: State of the Art

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome

Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review

Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry

Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder

Rethinking antiphospholipid syndrome to guide future management and research

Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review

"APS pregnancy - The offspring"

New and upcoming treatments in antiphospholipid syndrome: A comprehensive review

An immunogenomic exome landscape of triple positive primary antiphospholipid patients

Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review

A qualitative investigation of the experiences of patients living with antiphospholipid antibodies